67 related articles for article (PubMed ID: 16574889)
1. Modulation of smooth muscle cell migration by members of the low-density lipoprotein receptor family.
Bujo H; Saito Y
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1246-52. PubMed ID: 16574889
[TBL] [Abstract][Full Text] [Related]
2. LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.
Zhu Y; Bujo H; Yamazaki H; Ohwaki K; Jiang M; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
Circ Res; 2004 Apr; 94(6):752-8. PubMed ID: 14764453
[TBL] [Abstract][Full Text] [Related]
3. LRP1B is a negative modulator of increased migration activity of intimal smooth muscle cells from rabbit aortic plaques.
Seki N; Bujo H; Jiang M; Tanaga K; Takahashi K; Yagui K; Hashimoto N; Schneider WJ; Saito Y
Biochem Biophys Res Commun; 2005 Jun; 331(4):964-70. PubMed ID: 15882972
[TBL] [Abstract][Full Text] [Related]
4. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages.
Ohwaki K; Bujo H; Jiang M; Yamazaki H; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1050-6. PubMed ID: 17332490
[TBL] [Abstract][Full Text] [Related]
5. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells.
Jiang M; Bujo H; Zhu Y; Yamazaki H; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
Biochem Biophys Res Commun; 2006 Oct; 348(4):1367-77. PubMed ID: 16919601
[TBL] [Abstract][Full Text] [Related]
6. LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors.
Tanaga K; Bujo H; Zhu Y; Kanaki T; Hirayama S; Takahashi K; Inoue M; Mikami K; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1422-8. PubMed ID: 15166012
[TBL] [Abstract][Full Text] [Related]
7. PAF-receptor is preferentially expressed in a distinct synthetic phenotype of smooth muscle cells cloned from human internal thoracic artery: functional implications in cell migration.
Stengel D; O'Neil C; Brochériou I; Karabina SA; Durand H; Caplice NM; Pickering JG; Ninio E
Biochem Biophys Res Commun; 2006 Aug; 346(3):693-9. PubMed ID: 16793019
[TBL] [Abstract][Full Text] [Related]
8. High glucose-induced upregulation of Rho/Rho-kinase via platelet-derived growth factor receptor-beta increases migration of aortic smooth muscle cells.
Akiyama N; Naruse K; Kobayashi Y; Nakamura N; Hamada Y; Nakashima E; Matsubara T; Oiso Y; Nakamura J
J Mol Cell Cardiol; 2008 Aug; 45(2):326-32. PubMed ID: 18561944
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro.
Zhu Y; Bujo H; Yamazaki H; Hirayama S; Kanaki T; Takahashi K; Shibasaki M; Schneider WJ; Saito Y
Circulation; 2002 Apr; 105(15):1830-6. PubMed ID: 11956127
[TBL] [Abstract][Full Text] [Related]
10. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
12. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
[TBL] [Abstract][Full Text] [Related]
13. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis.
Vogt F; Zernecke A; Beckner M; Krott N; Bosserhoff AK; Hoffmann R; Zandvoort MA; Jahnke T; Kelm M; Weber C; Blindt R
J Am Coll Cardiol; 2008 Jul; 52(4):302-11. PubMed ID: 18634987
[TBL] [Abstract][Full Text] [Related]
14. Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathway.
Weiss S; Frischknecht K; Greutert H; Payeli S; Steffel J; Lüscher TF; Carrel TP; Tanner FC
J Vasc Res; 2007; 44(2):149-56. PubMed ID: 17264516
[TBL] [Abstract][Full Text] [Related]
15. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL
Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725
[TBL] [Abstract][Full Text] [Related]
16. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.
Yang YB; Yang YX; Su B; Tang YL; Zhu BY; Hu ZW; Li GY; Li YJ; Liao DF
Eur J Pharmacol; 2007 Sep; 570(1-3):125-34. PubMed ID: 17628533
[TBL] [Abstract][Full Text] [Related]
17. Enhanced activity of very low density lipoprotein receptor II promotes SGC7901 cell proliferation and migration.
Yang P; Liu Z; Wang H; Tian J; Li Y; Zong Y; Qu S
Life Sci; 2009 Mar; 84(13-14):402-8. PubMed ID: 19167408
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1.
Banerjee S; Sengupta K; Dhar K; Mehta S; D'Amore PA; Dhar G; Banerjee SK
Mol Carcinog; 2006 Nov; 45(11):871-80. PubMed ID: 16847823
[TBL] [Abstract][Full Text] [Related]
19. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.
Jiang M; Bujo H; Ohwaki K; Unoki H; Yamazaki H; Kanaki T; Shibasaki M; Azuma K; Harigaya K; Schneider WJ; Saito Y
J Clin Invest; 2008 Aug; 118(8):2733-46. PubMed ID: 18618022
[TBL] [Abstract][Full Text] [Related]
20. Vitronectin inhibits plasminogen activator inhibitor-1-induced signalling and chemotaxis by blocking plasminogen activator inhibitor-1 binding to the low-density lipoprotein receptor-related protein.
Kamikubo Y; Neels JG; Degryse B
Int J Biochem Cell Biol; 2009 Mar; 41(3):578-85. PubMed ID: 18703159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
